Publications by authors named "Keith Alcorn"

Claim this Profile
A
A need for implementation science to optimise the use of evidence-based interventions in HIV care: A systematic literature review.
Joseph Cox, Cassidy Gutner, Nadine Kronfli, Anna Lawson, Michele Robbins, Keith Alcorn

PLoS One· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HIV in 2019: it's all about dolutegravir.
Keith Alcorn

BMJ· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Haploidentical in utero hematopoietic cell transplantation improves phenotype and can induce tolerance for postnatal same-donor transplants in the canine leukocyte adhesion deficiency model.
William H Peranteau, Todd E Heaton, Yu-Chen Gu, Susan W Volk, Thomas R Bauer, Keith Alcorn

Biol Blood Marrow Transplant· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mixed co-receptor use associated with lower CD4 count.
Kelly Morris, Keith Alcorn

IAPAC Mon· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Delaying maternal NVP-based ART more effective.
Keith Alcorn

IAPAC Mon· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TMC125 study highlights failing NNRTI regimen task.
Keith Alcorn

IAPAC Mon· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
After Toronto, 46th ICAAC offers back to basics.
Keith Alcorn, Edwin J Bernard, Michael Carter, Adam Legge, Mark Mascolini

IAPAC Mon· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is PEPFAR tackling HIV drug supply in wrong way?
Keith Alcorn

IAPAC Mon· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Resistance: what are the implications for treatment?
Keith Alcorn

IAPAC Mon· March 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Abbott announces RTV price concessions.
Keith Alcorn

IAPAC Mon· March 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
4
400 percent ritonavir price hike.
Keith Alcorn

IAPAC Mon· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rapamycin is active against B-precursor leukemia in vitro and in vivo, an effect that is modulated by IL-7-mediated signaling.
Valerie I Brown, Junjie Fang, Keith Alcorn, Rosalind Barr, Jenny M Kim

Proc Natl Acad Sci U S A· December 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis